2025年5月25日 周日
Home > Archive>Volume 30, Issue 7, 2022 >611-617. DOI:10.20039/j.cnki.1007-3949.2022.07.010
PDF HTML XML Export Cite reminder
Meta-analysis based on the correlation coefficient between galectin-3 and the degree of coronary artery disease
Author:
Affiliation:

1.Guangxi University of Chinese Medicine, Nanning, Guangxi 530001, China;2.Cardiovascular Department of the First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, Guangxi 530001, China)

Clc Number:

R5

  • Article
    • | |
  • Metrics
    • |
  • Reference [41]
    • | | | |
  • Comments
    Abstract:

    Aim To study the correlation between galectin-3 (Gal-3) and the severity of coronary artery disease by Meta-analysis. Methods Through searching the related study on Gal-3 and coronary artery lesions in PubMed, Cochrane Library, Embase, CNKI, Wanfang and VIP internet databases, two researchers screened the literature and extracted data respectively. WPS software was used to transform the correlation coefficient, Fisher's Z transformation and inverse transformation. Revman 5.3 software was used to perform Meta analysis, heterogeneity test and sensitivity analysis. Stata 14.0 software was used to perform publication bias analysis. Results 14 studies involving 1 560 patients with coronary heart disease were included in this study. According to the Meta-analysis results of the correlation between Gal-3 and genisi score, the summary Fisher'Z was 0.79, I2 was 12% (P＜0.01), and the summary r was 0.66. Conclusion The concentration of Gal-3 in blood is closely related to the degree of coronary artery stenosis. With the increase of Gal-3 concentration in blood, it may indicate the aggravation of coronary artery stenosis.

    Reference
    [1] WANG L, GUO X L.Molecular regulation of galectin-3 expression and therapeutic implication in cancer progression.Biomed Pharmacother, 6,8:165-171.
    [2] MARTNEZ-MARTNEZ E, CALVIER L, ROSSIGNOL P, et al.Galectin-3 inhibition prevents adipose tissue remodelling in obesity.Int J Obes (Lond), 6,0(6):1034-1038.
    [3] LU Y, ZHANG M, ZHAO P, et al.Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in ApoE-deficient mice.Mol Med Rep, 7,6(1):647-653.
    [4] LIAO Y H, TENG M S, JUANG J J, et al.Genetic determinants of circulating galectin-3 levels in patients with coronary artery disease.Mol Genet Genomic Med, 0,8(9):e1370.
    [5] SUN Z, ZHANG L, LI L, et al.Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt.Am J Physiol Heart Circ Physiol, 1,0(1):H364-H380.
    [6] 喻晖.不同类型冠心病患者血浆半乳凝素-3水平分析.南昌:南昌大学, 2013.YU H.Analysis of plasma galectin-3 level in patients with different types of coronary artery disease(CHD).Nanchang:Nanchang University, 2013.
    [7] 吕红根.血清半乳糖凝集素-3水平与冠状动脉粥样硬化严重程度相关性研究.石家庄:河北医科大学, 2018.LU H G.Relationship between serum galectin-3 levels and the severity of coronary atherosclerosis .Shijiazhuang:Hebei Medical University, 2018.
    [8] 白晓悦.冠心病患者血清半乳糖凝集素-3与冠脉病变严重程度的相关性研究.延安:延安大学, 2018.BAI X Y.Correlation between galectin-3 and severity of coronary artery disease in patients with coronary heart disease.Yan’an:Yan’an University, 2018.
    [9] 邓居敏.Meta分析中数据转换方法研究.广州:南方医科大学, 2014.DENG J M.The data transformation methods in Meta-analysis.Guangzhou:Southern Medical University, 2014.
    [10] 魏雪梅, 张永刚, 陶华, 等.应用R软件Meta程序包与metafor程序包实现相关系数数据的Meta分析.中国循证医学杂志, 5,5(7):855-860.WEI X M, ZHANG Y G, TAO H, et al.How to perform Meta for package Meta-analysis of correlation coefficients using Meta package and in R.Chin J Evid-based Med, 5,5(7):855-860.
    [11] 秦月.冠心病患者半乳糖凝集素-3与冠脉病变程度及预后的相关性研究.滨州:滨州医学院, 2015.QIN Y.Asossiation of galectin-3 with the severity of coronary artery lesion and prognosis of coronary artery disease.Binzhou:Binzhou Medical University, 2015.
    [12] 刘蕾.血清半乳凝素-3和高敏C反应蛋白与冠心病的相关性研究.新乡:新乡医学院, 2013.LIU L.Relationship between serum galectins-3 and high sensitive c reactive protein and coronary atherosclerotic heart disease.Xinxiang:Xinxiang Medical University, 2013.
    [13] 李庆宽.半乳糖凝集素3在冠心病患者中的水平及临床价值.长沙:中南大学, 2013.LI Q K.The levels of galectin-3 and its value in patients with coronary heart disease.Changsha:Central South University, 2013.
    [14] 孙志明.血清半乳糖凝集素-3及C-反应蛋白水平与冠心病患者冠状动脉Gensini评分相关性分析.中国实用医刊, 7,4(14):15-18.SUN Z M.Correlation between serum galectin-3 and C-reactive protein levels and coronary artery Gensini score in patients with coronary heart disease.Chin J Prac Med, 7,4(14):15-18.
    [15] 寇城坤, 王琼英, 李彩娥, 等.原发性高血压患者血压变异性与左心室质量指数相关系数的Meta分析.兰州大学学报(医学版), 0,6(6):1-8.KOU C K, WANG Q Y, LI C E, et al.Relationship between blood pressure variability and left ventricular mass index based on correlation coefficient in patients with essential hypertension:a Meta-analysis.Lanzhou Univ J Med Sci, 0,6(6):1-8.
    [16] 汪秀莲.血清半乳糖凝集素-3及炎症因子与冠脉病变程度和主要心脏不良事件的相关性.合肥:安徽医科大学, 2017.WANG X L.Correlation between serum galetin-3, inflammatory factors and the severity of coronary lesion and major adverse cardiac events.Hefei:Anhui Medical University, 2017.
    [17] 罗倩.Galectin-3、MIF评估急性冠脉综合征患者冠脉病变程度及预后的临床价值.衡阳:南华大学, 2018.LUO Q.Clinical value of serum galectin-3 and mif in assessing coronary lesions and prognosis in patients with acute coronary syndrome.Hengyang:University of South China, 2018.
    [18] LIU T, HAN C, SUN L, et al.Association between new circulating proinflammatory and anti-inflammatory adipocytokines with coronary artery disease.Coron Artery Dis, 9,0(7):528-535.
    [19] 张育民, 李庆宽, 全勇, 等.急性心肌梗死患者血清半乳糖凝集素3水平与冠状动脉病变的相关性.中国动脉硬化杂志, 4,2(6):591-594.ZHANG Y M, LI Q K, QUANG Y, et al.Correlation between galectin-3 and coronary lesion in patients with acute myocardial infarction.Chin J Arterioscler, 4,2(6):591-594.
    [20] AKSAN G, GEDIKLI O, KESKIN K, et al.Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis?.J Investig Med, 6,4(3):764-770.
    [21] GUCUK I E, AKIN S S, KAFES H, et al.Evaluation of galectin-3 levels in acute coronary syndrome.Ann Cardiol Angeiol (Paris), 6,5(1):26-30.
    [22] LI X, QIU Q, TONG Q, et al.Value of galectin-3 in the diagnosis of acute coronary syndrome and the assessment of coronary artery lesions.Biomark Med, 1,5(9):647-657.
    [23] 杨濛, 白鹏, 刘镇, 等.冠心病患者血清锌指转录因子2和半乳糖凝集素-3水平与冠状动脉病变程度的相关性.临床内科杂志, 1,8(5):347-348.YANG M, BAI P, LIU Z, et al.Correlation between serum zinc finger transcription factor 2 and galectin-3 levels and the degree of coronary artery disease in patients with coronary heart disease.J Clin Intern Med, 1,8(5):347-348.
    [24] 曾宪涛, 刘慧, 陈曦, 等.Meta分析系列之四:观察性研究的质量评价工具.中国循证心血管医学杂志, 2,4(4):297-299.ZENG X T, LIU H, CHEN X, et al.Meta analysis series 4:quality evaluation tools for observational research.Chin J Evid Based Cardiovasc Med, 2,4(4):297-299.
    [25] MA L L, WANG Y Y, YANG Z H, et al.Methodological quality (risk of bias) assessment tools for primary and secondary medical studies:what are they and which is better?.Mil Med Res, 0,7(1):7.
    [26] BCK M, YURDAGUL A J, TABAS I, et al.Inflammation and its resolution in atherosclerosis:mediators and therapeutic opportunities.Nat Rev Cardiol, 9,6(7):389-406.
    [27] CHISTIAKOV D, MELNICHENKO A A, GRECHKO A V, et al.Potential of anti-inflammatory agents for treatment of athero-sclerosis.Exp Mol Pathol, 8,4(2):114-124.
    [28] 于永慧, 董瑞红, 刘剑刚, 等.不同阶段ApoE－/－小鼠动脉粥样硬化炎症差异基因表达的比较研究.中国病理生理杂志, 9,5(9):1694-1699.YU Y H, DONG R H, LIU J G, et al.Preliminary comparison of inflammatory differential gene expression during atherosclerosis in ApoE－/－ mice.Chin J Pathophysiol, 9,5(9):1694-1699.
    [29] 吐尔孙阿依·依斯米提拉, 阿里米江·阿布里米提, 穆叶赛·尼加提.急性心肌梗死患者C反应蛋白与白蛋白比值与冠状动脉狭窄程度的相关性.中国动脉硬化杂志, 1,9(10):869-874.TUERSUNAYI·YISIMITILA, ALIMIJIANG·ABILIMITI, MUYESAI·NEJATI.Relationship between C-reactive protein to albumin ratio and the degree of coronary artery disease in patients with acute myocardial infarction.Chin J Arterioscler, 1,9(10):869-874.
    [30] DONG R, ZHANG M, HU Q, et al.Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review).Int J Mol Med, 8,1(2):599-614.
    [31] VAN DER HOEVEN N W, HOLLANDER M R, YILDIRIM C, et al.The emerging role of galectins in cardiovascular disease.Vascul Pharmacol, 6,1:31-41.
    [32] MORTENSEN M B, FUSTER V, MUNTENDAM P, et al.Negative risk markers for cardiovascular events in the elderly.J Am Coll Cardiol, 9,4(1):1-11.
    [33] S＇WIECKI P, SAWICKI R, KNAPP M, et al.Galectin-3 as the prognostic factor of adverse cardiovascular events in long-term follow up in patients after myocardial infarction:a pilot study.J Clin Med, 0,9(6):1640.
    [34] SCIACCHITANO S, LAVRA L, MORGANTE A, et al.Galectin-3:one molecule for an alphabet of diseases, from a to Z.Int J Mol Sci, 8,9(2):379.
    [35] KOGA M, KARIM M R, KURAMOCHI M, et al.Appearance of heterogeneous macrophages during development of isoproterenol-induced rat myocardial fibrosis.Toxicol Pathol, 1,9(5):1048-1061.
    [36] DI G K, SOMERVILLE M, BIANCO R, et al.Galectin-3 identifies a subset of macrophages with a potential beneficial role in atherosclerosis.Arterioscler Thromb Vasc Biol, 0,0(6):1491-1509.
    [37] 彭进, 王玉, 张琼, 等.人冠状动脉内半乳糖凝集素3水平与斑块稳定性的相关性研究.中国病理生理杂志, 0,6(9):1557-1564.PENG J, WANG Y, ZHANG Q, et al.Expression of galectin-3 in human coronary artery and its correlation with plaque structural stability.Chin J Pathophysiol, 0,6(9):1557-1564.
    [38] 党晶艺, 郝启萌, 冯品, 等.血清Gal-3、C1q水平与冠心病的相关性分析.疑难病杂志, 9,8(5):433-436.DANG J Y, HAO Q M, FENG P.Analysis of the correlation between serum Gal-3 and Clq levels and coronary heart disease.Chin J Diffic and Compl Cas, 9,8(5):433-436.
    [39] LORENZO-ALMORS A, PELLO A, ACEA , et al.Galectin-3 is associated with cardiovascular events in post-acute coronary syndrome patients with type-2 diabetes.J Clin Med, 0,9(4):1105.
    [40] SUN J, ZHANG L, FANG J, et al.Galectin-3 mediates high-glucose-induced cardiomyocyte injury by the NADPH oxidase/reactive oxygen species pathway.Can J Physiol Pharmacol, 0,8(11):826-833.
    [41] 何杰, 戴亨华, 杜令, 等.血清PTX3和Gal-3在高血压合并冠状动脉粥样硬化性心脏病患者中的水平变化及其临床意义.国际检验医学杂志, 0,1(5):536-539.HE J, DAI H H, DU L, et al.The concentration change and clinical significance of serum PTX 3 and Gal-3 levels in patients with hypertension and coronary heart disease.Int J Lab Med, 0,1(5):536-539.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

ZHENG Guokun, HE Guixin, FENG Yufei, HU Mengxian, LIU Shihai, WEI Juan. Meta-analysis based on the correlation coefficient between galectin-3 and the degree of coronary artery disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(7):611-617.

Copy
Share
Article Metrics
  • Abstract:161
  • PDF: 585
  • HTML: 0
  • Cited by: 0
History
  • Received:September 21,2021
  • Online: July 11,2022
Article QR Code

You are the 49009 visitor

Post Code：421001 Fax：0734-8160523

Phone：0734-8160765 E-mail：dmzzbjb@163.net

Editorial Office of Chinese Journal of Arteriosclerosis ® 2025